Hartford Investment Management Co. purchased a new position in Cantel Medical Corp. (NYSE:CMD) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,300 shares of the company’s stock, valued at approximately $217,000.

A number of other hedge funds have also bought and sold shares of CMD. Globeflex Capital L P acquired a new stake in shares of Cantel Medical in the 2nd quarter valued at about $114,000. LS Investment Advisors LLC acquired a new stake in shares of Cantel Medical in the second quarter valued at about $172,000. Airain ltd acquired a new position in Cantel Medical during the second quarter worth approximately $201,000. Punch & Associates Investment Management Inc. acquired a new position in Cantel Medical during the second quarter worth approximately $212,000. Finally, Riverhead Capital Management LLC acquired a new position in Cantel Medical during the second quarter worth approximately $218,000. Hedge funds and other institutional investors own 84.98% of the company’s stock.

A number of brokerages have weighed in on CMD. Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Zacks Investment Research raised Cantel Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $91.67.

In related news, EVP Eric W. Nodiff sold 2,868 shares of the stock in a transaction on Friday, October 20th. The stock was sold at an average price of $97.55, for a total value of $279,773.40. Following the completion of the sale, the executive vice president now directly owns 39,102 shares in the company, valued at $3,814,400.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Charles M. Diker sold 20,500 shares of the stock in a transaction on Wednesday, October 4th. The shares were sold at an average price of $99.15, for a total value of $2,032,575.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 36,368 shares of company stock valued at $3,576,028. 12.30% of the stock is currently owned by corporate insiders.

Shares of Cantel Medical Corp. (NYSE CMD) traded down $2.89 during trading hours on Wednesday, hitting $100.49. The stock had a trading volume of 208,500 shares, compared to its average volume of 146,027. The company has a current ratio of 2.41, a quick ratio of 1.49 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $4,321.89, a PE ratio of 49.70 and a beta of 1.24. Cantel Medical Corp. has a 12 month low of $69.21 and a 12 month high of $108.00.

Cantel Medical (NYSE:CMD) last issued its quarterly earnings results on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.02. The business had revenue of $205.50 million during the quarter, compared to analysts’ expectations of $200.32 million. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. analysts forecast that Cantel Medical Corp. will post 2.34 earnings per share for the current year.

The business also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be paid a $0.085 dividend. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a dividend yield of 0.17%. The ex-dividend date is Tuesday, January 16th. Cantel Medical’s payout ratio is 8.19%.

TRADEMARK VIOLATION NOTICE: “Hartford Investment Management Co. Invests $217,000 in Cantel Medical Corp. (CMD)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/12/06/hartford-investment-management-co-invests-217000-in-cantel-medical-corp-cmd.html.

Cantel Medical Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.